We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Cardiac iPSCs for Drug Discovery

Video   Apr 27, 2016

 

Heart disease is the cause of morbidity and mortality in the industrialized world. While the use of human induced pluripotent stem cell (iPSCs) in regenerative medicine is a long-term goal. Recent technological advancement has enabled the generation of patient-specific and disease-specific human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) in vitro. iPSC-CMs carry all the genetic information and therefore may be an ideal platform for elucidating disease modeling, drug screening, and cell therapy. Here I will discuss recent advances in this technology in the cardiovascular field.

 
Company Information
 
 
Advertisement
 

Recommended Videos

Giant Spider Provides Promise of Pain Relief for Irritable Bowel Syndrome

Video

Molecules from the venom of one of the world’s largest spiders could help researchers tailor pain blockers for people with irritable bowel syndrome (IBS).

WATCH NOW

Duchenne Muscular Dystrophy and Gene Therapy

Video

The most common form of muscular dystrophy is called Duchenne. The disease is caused by a faulty gene that interferes with how muscle cells produce a protein called dystrophin. It’s part of a vital protein complex that works to strengthen and protect muscle fibers.

WATCH NOW

Gene Therapy: Your Questions Answered

Video

This video aims to address frequently questions, hopes and concerns that patients and caregivers, across many different diseases, have about gene therapy.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Biopharma Cancer Research Cell Science Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE